This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n13http://bio2rdf.org/drugbank:
n10http://linked.opendata.cz/resource/drugbank/drug/DB08266/identifier/pdb/
n5http://linked.opendata.cz/resource/drugbank/drug/DB08266/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n12http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n8http://linked.opendata.cz/resource/drugbank/drug/DB08266/identifier/pubchem-substance/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://linked.opendata.cz/resource/drugbank/drug/DB08266/identifier/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/ontology/drugbank/
n7http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB08266
rdf:type
n6:Drug
n6:group
experimental
owl:sameAs
n12:DB08266 n13:DB08266
dcterms:title
methyl [(1E,5R)-5-{(3S)-3-[(2E,4E)-2,5-dimethylocta-2,4-dienoyl]-2,4-dioxo-3,4-dihydro-2H-pyran-6-yl}hexylidene]carbamate
adms:identifier
n5:46937136 n8:99444737 n9:DB08266 n10:NE6
n6:IUPAC-Name
n7:271B4778-363D-11E5-9242-09173F13E4C5
n6:InChI
n7:271B477E-363D-11E5-9242-09173F13E4C5
n6:Molecular-Formula
n7:271B477D-363D-11E5-9242-09173F13E4C5
n6:Molecular-Weight
n7:271B477A-363D-11E5-9242-09173F13E4C5
n6:Monoisotopic-Weight
n7:271B477B-363D-11E5-9242-09173F13E4C5
n6:SMILES
n7:271B477C-363D-11E5-9242-09173F13E4C5
n6:Water-Solubility
n7:271B4776-363D-11E5-9242-09173F13E4C5
n6:logP
n7:271B4774-363D-11E5-9242-09173F13E4C5 n7:271B4777-363D-11E5-9242-09173F13E4C5
n6:logS
n7:271B4775-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Acceptor-Count
n7:271B4784-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Donor-Count
n7:271B4785-363D-11E5-9242-09173F13E4C5
n6:InChIKey
n7:271B477F-363D-11E5-9242-09173F13E4C5
n6:Polar-Surface-Area--PSA-
n7:271B4780-363D-11E5-9242-09173F13E4C5
n6:Polarizability
n7:271B4782-363D-11E5-9242-09173F13E4C5
n6:Refractivity
n7:271B4781-363D-11E5-9242-09173F13E4C5
n6:Rotatable-Bond-Count
n7:271B4783-363D-11E5-9242-09173F13E4C5
n6:Bioavailability
n7:271B478A-363D-11E5-9242-09173F13E4C5
n6:Ghose-Filter
n7:271B478C-363D-11E5-9242-09173F13E4C5
n6:MDDR-Like-Rule
n7:271B478D-363D-11E5-9242-09173F13E4C5
n6:Number-of-Rings
n7:271B4789-363D-11E5-9242-09173F13E4C5
n6:Physiological-Charge
n7:271B4788-363D-11E5-9242-09173F13E4C5
n6:Rule-of-Five
n7:271B478B-363D-11E5-9242-09173F13E4C5
n6:Traditional-IUPAC-Name
n7:271B4779-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-acidic-
n7:271B4786-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-basic-
n7:271B4787-363D-11E5-9242-09173F13E4C5